These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9470856)

  • 41. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
    Domagala W; Harezga B; Szadowska A; Markiewski M; Weber K; Osborn M
    Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
    Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
    J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
    Yoder BJ; Wilkinson EJ; Massoll NA
    Breast J; 2007; 13(2):172-9. PubMed ID: 17319859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment.
    Linderholm B; Andersson J; Lindh B; Beckman L; Erlanson M; Edin K; Tavelin B; Grankvist K; Henriksson R
    Eur J Cancer; 2004 Jan; 40(1):33-42. PubMed ID: 14687787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MIB-1 proliferative activity in invasive breast cancer measured by image analysis.
    Querzoli P; Albonico G; Ferretti S; Rinaldi R; Magri E; Indelli M; Nenci I
    J Clin Pathol; 1996 Nov; 49(11):926-30. PubMed ID: 8944614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to correspondence on 'low concordance of biomarkers in histopathological and cytological material from breast cancer'.
    Stålhammar G; Hartman J
    Histopathology; 2015 Apr; 66(5):756-8. PubMed ID: 25040089
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression of periostin in human breast cancer.
    Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
    J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
    Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
    J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer.
    Schmitt F; Vielh P
    Histopathology; 2015 Jan; 66(2):314-5. PubMed ID: 24750212
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
    Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
    Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma.
    Turunen N; Karihtala P; Mantyniemi A; Sormunen R; Holmgren A; Kinnula VL; Soini Y
    APMIS; 2004 Feb; 112(2):123-32. PubMed ID: 15056229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status.
    Kuvaja P; Hulkkonen S; Pasanen I; Soini Y; Lehtonen S; Talvensaari-Mattila A; Pääkkö P; Kaakinen M; Autio-Harmainen H; Hurskainen T; Lehenkari P; Turpeenniemi-Hujanen T
    Exp Cell Res; 2012 Jun; 318(10):1094-103. PubMed ID: 22465225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
    Ross DS; Hoda SA
    Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
    Miše I; Vučić M
    Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.
    McCann AH; Kirley A; Carney DN; Corbally N; Magee HM; Keating G; Dervan PA
    Br J Cancer; 1995 May; 71(5):981-5. PubMed ID: 7734324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P53 expression in patients with malignant and benign breast diseases.
    Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
    Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma.
    Niewiadomska H; Jeziorski A; Olborski B
    J Exp Clin Cancer Res; 1998 Dec; 17(4):503-10. PubMed ID: 10089075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.